EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)

Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, Joe Yeong, Guray Akturk, Michael Angelo, Carmen Ballesteros-Merino, Peter Bankhead, Subham Basu, Jorge M Blando, Saska Brajkovic, Marco Cassano und 48 weitere

Journal for ImmunoTherapy of Cancer · 2025-12 · 13 (12) · e012280

DOI: 10.1136/jitc-2025-012280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 21.12.2025. Verfasst von Sam Sater und 59 weiteren Autor:innen. Beteiligte Einrichtung: HAS Consulting, Miami, Florida, USA. Hauptthemen laut MEDLINE: Immunohistochemistry, Neoplasms, Immunotherapy, Fluorescent Antibody Technique. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiplex immunofluorescence and immunohistochemistry (mIF/IHC) are increasingly employed antibody-based technologies that use tissue sparingly and facilitate the detection of co-localized or neighboring biomarkers. Specifically, these platforms enable spatial analyses of the tumor microenvironment as well as extended applications, for example, describing normal tissue anatomy, autoimmunity, infectious diseases, etc. mIF/IHC has greatly enhanced biomarker discovery efforts, and a growing number of studies suggest superiority to traditional IHC. Standardization of staining approaches, reporting of image analysis strategies and resultant data is critical for facilitating cross-study comparisons, validation, deployment, and generalization of findings. To address this challenge, The Society for Immunotherapy of Cancer (SITC) previously published two articles providing best practice guidelines for mIF/IHC staining, image analysis, and data sharing. Here, SITC convened stakeholders to develop the third article in the series, a consensus checklist for scientific reporting of mIF/IHC data to support and complement the best practice guidelines. The checklist includes critical components of mIF/IHC applications to be defined within publications such as detailed descriptions of analytical validation; image acquisition, selection, and registration methods; and cell clustering and spatial analysis strategies, amongst others. Such information will help with data reproducibility and comparison across studies towards future drug and assay development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunohistochemistryNeoplasmsImmunotherapyFluorescent Antibody TechniqueBiomarkers, TumorHumansTumor Microenvironment

Stichwörter der Autor:innen

BiomarkerImmunotherapyPathologyTumor microenvironment - TME

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • HAS Consulting, Miami, Florida, USA.
  • Providence Molecular Genomics Laboratory, Portland, Oregon, USA.
  • Earle A Chiles Research Institute, Portland, Oregon, USA.
  • Daiichi Sankyo Inc, Basking Ridge, New Jersey, USA.
  • Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore.

Zitieren

APA

Sater, S., Bifulco, C. B., Rodriguez-Canales, J., Yeong, J., Akturk, G., Angelo, M., Ballesteros-Merino, C., Bankhead, P., Basu, S., Blando, J. M., Brajkovic, S., Cassano, M., Chen, B. J., Coskun, A. F., Cottrell, T. R., De Andrea, C. E., Edwards, R. H., Egelston, C., Engle, L. L., …, & Taube, J. M. (2025). Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI). Journal for ImmunoTherapy of Cancer, 13(12), e012280. https://doi.org/10.1136/jitc-2025-012280

Vancouver

Sater S, Bifulco CB, Rodriguez-Canales J, Yeong J, Akturk G, Angelo M, et al. Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI). Journal for ImmunoTherapy of Cancer. 2025;13(12):e012280. doi:10.1136/jitc-2025-012280

BibTeX
@article{Sater2025,
  author = {Sater, Sam and Bifulco, Carlo B and Rodriguez-Canales, Jaime and Yeong, Joe and Akturk, Guray and Angelo, Michael and Ballesteros-Merino, Carmen and Bankhead, Peter and Basu, Subham and Blando, Jorge M and Brajkovic, Saska and Cassano, Marco and Chen, Benjamin J and Coskun, Ahmet F and Cottrell, Tricia R and De Andrea, Carlos E and Edwards, Robin H and Egelston, Colt and Engle, Logan L and Ernstoff, Marc S and Fan, Rong and Feldman, Michael and Fox, Bernard A and Galon, Jerome and Gartrell, Robyn and Gnjatic, Sacha and Green, Benjamin F and Gulley, James L and Hellebust, Anne and Hewitt, Stephen and Hollmann, Travis J and Horn, Lucas A and Howat, William J and Hoyt, Clifford C and Jensen, Shawn M and Kulasinghe, Arutha and Lassoued, Wiem and Lott, Steven and Mansfield, James and Marwitz, Sebastian and Netto, George and Page, David B and Parra, Edwin and Rimm, David L and Rodig, Scott J and Salgado, Roberto and Schapiro, Denis and Schalper, Kurt A and Sunshine, Joel C and Surace, Michael J and Szalay, Alexander S and Thurin, Magdalena and Villasboas, Jose C and Wharton, Keith and Wistuba, Ignacio I and Yearley, Jennifer H and Yuan, Yinyin and Zaki, Geroge and Ziai, James and Taube, Janis M},
  title = {Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {12},
  pages = {e012280},
  doi = {10.1136/jitc-2025-012280}
}
Kostenlos starten →